Hughes Financial Services’s Terns Pharmaceuticals TERN Stock Holding History

Hughes Financial Services’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$53	–	1935
2026 Q1	$53	Sell	1 -2	-67%	-$82	﹤0.01%	1439
2025 Q4	$121	Buy	+3	New	+$69	﹤0.01%	1042

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hughes Financial Services's TERN Position: Q2 2026 in Review

Hughes Financial Services sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1 share — an estimated $53 sold.

Hughes Financial Services first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $121 in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Hughes Financial Services reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Hughes Financial Services sold 1 Terns Pharmaceuticals share in Q2 2026, an estimated $53.
Hughes Financial Services first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Hughes Financial Services's Terns Pharmaceuticals position peaked at $121 in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.